ArticleResearch square2023

Dolutegravir use over 48 weeks is not associated with worsening insulin resistance and pancreatic beta cell function in a cohort of HIV-infected Ugandan adults.

Frank Mulindwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.